Event Report 2022
-
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" held
-
Patient Organization Collaboration Promotion Committee
The 40th Pharmaceutical Manufacturers Association of Japan (PMAJ) Patient Group Seminar held
Thinking Together and Taking the First Step: Patient and Public Involvement in Healthcare (PPI) -
International Committee
Held the 3rd Japan-Vietnam Joint Symposium
-
APAC Project
The 1st APAC e-labeling Regulators' Workshop held
-
Drug Evaluation Committee
The "General Meeting of the Drug Evaluation Committee for FY2022" was held
Paving the way for the future of healthcare through Digital Transformation! ～From Disease to Pre-Disease and Well being -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
Secretariat
The 21st Pharmaceutical Association of Japan Forum held
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
International Committee
Held a special session at the 9th Nikkei-FT Conference on Infectious Diseases
Toward the creation of a drug discovery ecosystem in the field of infectious diseases - Focusing on collaboration between industry, government, and academia -
ICH Project
ICH Incheon Meeting" was held.
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
-Drug Resistance (AMR) Awareness Month -
Pharmaceutical Industry Policy Institute
The Economics of Invention", a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Culture Award.
-
International Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference held
-
Public Relations Committee
The 38th Public Relations Seminar held
-ESG Management, Disclosure, and the Relationship with Society -
Biopharmaceutical Committee
Report on "BioJapan 2022" and its participation.
About the Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Relations Committee
The Pharmaceutical Association of Japan (PAJ) Chairman speaks at a special session of "Nikkei Cross Health EXPO 2022".
Direction and Challenges of Pharmaceutical Companies' Transformation in the Era of Innovation Ecosystem -
Code Compliance Promotion Committee
The "2022 Meeting of Code Administration Managers and Practitioners" was held.
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan held
Current and Future Human Resource Development for Regulatory Science -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Recognition of the current situation and issues surrounding the pharmaceutical industry and the basic framework for solving them -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Aiming for Appropriate Use of Drugs - To deliver reliable drug information to patients -
International Committee
The 2nd Japan-Malaysia Symposium was held
-
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Athens Meeting" held in a hybrid format for the first time
-
Drug Evaluation Committee
The "Joint Meeting of the Drug Evaluation Committee and the Regulatory Affairs Committee" was held.
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Relations Committee
The 37th Public Relations Seminar held
～News Commentary and News Program Production Today -
APAC Project
The 11th APAC (Asian Pharmaceutical Association Conference) was held.
-Mission: Rapidly Deliver Innovative Medicines to the People of Asia
Theme: "Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade of APAC -
Product Information Summary Review Meeting
Held the "FY2021 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice".
-
Industry Policy Committee
Held a briefing session on the Cost-Effectiveness Evaluation System
-
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
ICH Project
Report on the "eCTD v4.0 (ICH M8) Notification Revision and Start of Operation Briefing Session
-
Code Compliance Promotion Committee
Held the "FY2021 Meeting of Compliance Managers and Practitioners
-
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
The 8th Japan-Thailand Joint Symposium" was held
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues